Skip to main content

Day: November 21, 2024

Risk Strategies Acquires Assets of Cornerstone Broker Insurance Services Agency Inc. and ARC Benefit Solutions

Employee Benefits specialist adds to leading national specialty practice BOSTON, Nov. 21, 2024 (GLOBE NEWSWIRE) — Risk Strategies, a leading North American specialty insurance brokerage and risk management and consulting firm, today announced it has acquired the assets of Ohio-based employee benefits specialty organization Cornerstone Broker Insurance Services Agency, Inc., an Ohio-based national provider of employee benefits solutions. The sale also included the assets of ARC Benefit Solutions, which provides ongoing support to employee benefit clients. Terms of the deal were not announced. Founded in 1985 as Cornerstone Broker Insurance Services Agency, Inc., the firm is a brokerage general agency (BGA) providing wholesale health insurance purchasing and general agency services to independent brokers across group, individual,...

Continue reading

JSC ‘Siguldas ciltslietu un mākslīgās apsēklošanas stacija‘ unaudited financial information for nine months of 2024

In the nine months of 2024, the net turnover was 1,193.3 thousand. EUR, which is 6.4% more than in the nine months of the previous year, but the profit before taxes was 84.4 thousand. EUR – by 31.9 thousand euro less compared to the corresponding period of the previous year. JSC ‘Siguldas ciltslietu un mākslīgās apsēklošanas stacija’ is the only producer of high-quality breeding bull semen and one of the largest suppliers of it in Latvia. The second largest field of the Company’s basic economic activities is the milk testing services. The Company also provides other breeding related services – consultations on issues of cattle breeding, feeding and keeping, evaluation of cow exterior, artificial insemination of cows, initial processing of the supervisory data. The Company offers Latvian farms to test genome samples of herd animals in the...

Continue reading

iCoreConnect Achieves Robust Revenue Growth in Q3 With Expanding Customer Base

OCOEE, Fla., Nov. 21, 2024 (GLOBE NEWSWIRE) — iCoreConnect, Inc. (NASDAQ: ICCT), a leading provider of cloud-based software and technology solutions, has announced its financial results for the third quarter ending September 30, 2024. Financial Highlights for Q3 2024Recurring revenue grew by 56% year-to-date as of September 30, 2024. Total revenue increased by 51% year-to-date as of September 30, 2024. Gross margin improved from 74% to 77% year-to-date.Recent Business Achievements and Partnerships:Expanded agreement with the Arizona Dental Association, adding iCoreClaims and iCorePay to its offerings. Secured a new endorsement agreement with the Delaware State Dental Society for five products. Acquired assets from Healthcare Circle of Excellence to enhance strategic capabilities. Divested our MSP Division to focus on higher-margin...

Continue reading

Progress Unveils Native Next.js Support in Sitefinity, Offering Maximum Flexibility to Create and Scale Digital Experiences

Latest Sitefinity release offers out-of-the-box native support for Next.js and Gen AI-powered content workflows–accelerating the delivery of digital experiences BURLINGTON, Mass., Nov. 21, 2024 (GLOBE NEWSWIRE) — Progress (Nasdaq: PRGS), the trusted provider of AI-powered infrastructure software, today announced new powerful capabilities and enhancements in the latest release of Progress® Sitefinity®. With this release, Sitefinity introduces native support for Next.js, a React framework, enabling organizations to leverage one of the fastest growing frontend frameworks for developers to create modern, state-of-the-art digital experiences. “Developers want to use their technology of choice when building digital experiences, and Sitefinity is now the right solution for React developers in addition to .NET developers,” said Loren...

Continue reading

Gildan Announces Private Offering of C$700 Million Senior Unsecured Notes

MONTREAL, Nov. 21, 2024 (GLOBE NEWSWIRE) — Gildan Activewear Inc. (GIL: TSX and NYSE) (“Gildan” or the “Company”) announced today that it has priced an inaugural offering of C$700 million aggregate principal amount of senior unsecured notes in two series (the “Notes”), consisting of C$500 million aggregate principal amount of 4.362% senior unsecured notes, Series 1, due 2029 (the “2029 Notes”) and C$200 million aggregate principal amount of 4.711% senior unsecured notes, Series 2, due 2031 (the “2031 Notes”). The 2029 Notes will be issued at par and bear interest at a rate of 4.362% per annum, payable semi-annually until maturity on May 22 and November 22 of each year, commencing on May 22, 2025. The 2031 Notes will be issued at par and bear interest at a rate of 4.711% per annum, payable semi-annually until maturity on May 22...

Continue reading

reAlpha Acquires USRealty and Invests in Unreal Estate to Gain Ability to Expand into 33 U.S. States

DUBLIN, Ohio, Nov. 21, 2024 (GLOBE NEWSWIRE) — reAlpha Tech Corp. (“reAlpha” or the “Company”) (Nasdaq: AIRE), a real estate technology company developing and commercializing artificial intelligence (“AI”) technologies, today announces the acquisition of USRealty Brokerage Solutions, LLC (“US Realty”) and an investment into Unreal Estate Inc. (“Unreal”). In connection with the acquisition and investment, US Realty entered into a services agreement with a broker from Unreal Estate LLC to provide broker services and facilitate access to brokerage licenses in up to 33 U.S. states. This agreement is expected to enable reAlpha’s expansion into such states, subject to the completion of all applicable regulatory and legal requirements. reAlpha expects to continue seeking additional brokerage licenses to expand its services nationwide...

Continue reading

Nanox Announces Third Quarter of 2024 Financial Results and Provides Business Update

Made progress deploying all components of the Nanox solution including Nanox.ARC and Nanox.AI Expanded US sales and support staff a key component of global strategic growth plan Management to host conference call and webcast Thursday, November 21, 2024 at 8:30 AM ET PETACH TIKVA, Israel, Nov. 21, 2024 (GLOBE NEWSWIRE) — November 21, 2024 — NANO-X IMAGING LTD (NASDAQ: NNOX) (“Nanox” or the “Company”), an innovative medical imaging technology company, today announced results for the third quarter ended September 30, 2024 and provided a business update. Recent Highlights:Generated $3.0 million in revenue in the third quarter of 2024, compared to $2.5 million in the third quarter of 2023.Continued to expand the US sales and support teams, and made progress in deployment, with dozens of units deployed globally.Growth of the...

Continue reading

MDWerks Announces Uplisting to OTCQB Venture Market

GREEN COVE SPRINGS, Fla., Nov. 21, 2024 (GLOBE NEWSWIRE) — MDWerks, Inc. (“MDWerks” or the “Company”) (OTC: MDWK), a forward-thinking company leading the charge in the world of sustainable technology, today announced that the Company’s stock has been approved by OTC Markets Group Inc. for uplisting from the OTC Pink Open Market to the OTCQB Venture Market, effective today, November 21, 2024. The Company’s stock will continue to trade under the ticker symbol “MDWK”. Steven Laker, CEO of MDWerks, commented, “Our uplisting to the OTCQB Venture Market is an exciting milestone for MDWerks and reflects our commitment to enhancing market visibility, improving transparency, increasing share liquidity, and building an expanded audience of potential investors.” OTC Markets Group Inc. is an operator of regulated markets for trading more than...

Continue reading

Dyadic Receives $3 Million Grant to Develop Cost-Effective Monoclonal Antibodies for RSV and Malaria Using C1 Platform Technology

Grant Received from the Bill & Melinda Gates Foundation to Fund Development of Affordable Therapeutics JUPITER, Fla., Nov. 21, 2024 (GLOBE NEWSWIRE) — Dyadic International, Inc. (NASDAQ: DYAI), a global biotechnology company, announced today that it has been awarded a $3 million grant from the Gates Foundation for the cell line development of monoclonal antibodies (mAbs) targeting respiratory syncytial virus (RSV) and malaria utilizing the company’s proprietary C1 protein production platform to provide globally accessible treatment options for underserved populations. RSV is a major cause of lower respiratory tract infection morbidity and mortality in children globally, causing 3.2–36 million hospitalizations and more than 100,000 deaths annually, 99% of which occur in low-income and middle-income countries (LMICs). In 2022,...

Continue reading

AssetMark Adds TIFIN AI Capabilities to Enhance and Scale its Industry-Leading Wealth Management Platform

TIFIN Sage’s AI-driven Technology Empowers AssetMark to Deliver Highly Personalized Solutions for Financial Advisors BOULDER, Colo. and CONCORD, Calif., Nov. 21, 2024 (GLOBE NEWSWIRE) — TIFIN Sage, an advanced AI-powered investment platform and a division of TIFIN, is pleased to announce an expanded collaboration with AssetMark, Inc., a leading provider of wealth management and technology solutions for financial advisors. AssetMark will incorporate TIFIN Sage’s cutting-edge AI capabilities into its wealth management platform through its investment consulting services, enabling AssetMark to streamline high-touch, personalized engagements. Through the integration of TIFIN Sage’s AI capabilities, AssetMark aims to enable its investment consultants to rapidly gather insights, align advisory firm inputs, and deliver tailored model portfolios...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.